Abstract:Cadmium (Cd) is a widely prevalent environmental pollutant that accumulates in the liver and induces liver injury. The mechanism of Cd-induced liver injury remains elusive. Our study aimed to clarify the mechanism by which changes in the gut microbiota contribute to Cd-induced liver injury. Here, a murine model of liver injury induced by chronic Cd exposure was used. Liver injury was assessed by biochemistry and histopathology. Expression profiles of genes involved in bile acid (BA) homeostasis, inflammation and injury were assessed via Realtime-PCR and Western-blot. 16S rRNA gene sequencing and mass spectrometry-based metabolomics were used to investigate changes in the gut microbiota and its metabolites in the regulation of Cd-induced liver injury. Here, we showed that Cd exposure induced hepatic ductular proliferation, hepatocellular damage and inflammatory infiltration in mice. Cd exposure induced gut microbiota dysbiosis and reduced the fecal bile salt hydrolase activity leading to an increase of tauro-β-muricholic acid levels in the intestine. Cd exposure decreased intestine FXR/FGF-15 signaling and promoted hepatic BA synthesis. Furthermore, the mice receiving fecal microbiota transplantation from Cd-treated mice showed reduced intestinal FXR/FGF-15 signaling, increased hepatic BA synthesis, and liver injury. However, the depletion of the commensal microbiota by antibiotics failed to change these indices in Cd-treated mice. Finally, the administration of the intestine-restricted FXR agonist fexaramine attenuated the liver injury, improved the intestinal barrier, and decreased hepatic BA synthesis in the Cd-treated mice. Our study identified a new mechanism of Cd-induced liver injury. Cd-induced gut microbiota dysbiosis, decreased feces BSH activity, and increased intestinal T-βMCA levels led to an inhibition of intestinal FXR/FGF-15 signaling and an increase in hepatic BA synthesis, ultimately facilitating the development of hepatic ductular proliferation, inflammation, and injury in mice. This study expands our understanding of the health hazards caused by environmental Cd pollution.

Cadmium exacerbates liver injury by remodeling ceramide metabolism: Multiomics and laboratory evidence

Cadmium Perturbed Lipid Profile and Induced Liver Dysfunction in Mice Through Phosphatidylcholine Remodeling and Promoting Arachidonic Acid Synthesis and Metabolism

Cadmium influence on lipid metabolism in Sprague–Dawley rats through linoleic acid and glycerophospholipid metabolism pathways

Cadmium causes hepatopathy by changing the status of DNA methylation in the metabolic pathway

Transcription Profiling of Cadmium-Exposed Livers Reveals Alteration of Lipid Metabolism and Predisposition to Hepatic Steatosis.

Cadmium exposure disturbs myocardial lipid signature and induces inflammation in C57BL/6J mice

Dual Role of Cadmium in Rat Liver: Inducing Liver Injury and Inhibiting the Progression of Early Liver Cancer.

Cadmium Exposure Impairs Skeletal Muscle Function by Altering Lipid Signature and Inducing Inflammation in C57BL/6J Mice

Gut Microbiota-Bile Acid-Intestinal Farnesoid X Receptor Signaling Axis Orchestrates Cadmium-Induced Liver Injury

Chronic cadmium exposure at environmental-relevant level accelerates the development of hepatotoxicity to hepatocarcinogenesis

Metabolomics in Liver Injury Induced by Dietary Cadmium Exposure and Protective Effect of Calcium Supplementation.

Cadmium induces liver dysfunction and ferroptosis through the endoplasmic stress-ferritinophagy axis

Cadmium exposure causes transcriptomic dysregulation in adipose tissue and associated shifts in serum metabolites

Cadmium Exposure: Mechanisms and Pathways of Toxicity and Implications for Human Health

Exposure to acute waterborne cadmium caused severe damage on lipid metabolism of freshwater fish, revealed by nuclear lipid droplet deposition in hepatocytes of rare minnow.

Cadmium aggravates liver injury by activating ferroptosis and neutrophil extracellular traps formation in Nile tilapia (Oreochromis niloticus)

Inhibition of Mitochondrial Fatty Acid Oxidation Contributes to Development of Nonalcoholic Fatty Liver Disease Induced by Environmental Cadmium Exposure

Cadmium exposure induces endothelial dysfunction via disturbing lipid metabolism in human microvascular endothelial cells

Identification of key genes and pathways and therapeutic agents in cadmium-treated liver cells: A bioinformatics study.

Transcriptomics integrated with metabolomics unravels the interweaving of inflammatory response and 1-stearoyl-2-arachidonoyl-sn-glycerol metabolic disorder in chronic cadmium exposure-induced hepatotoxicity

Cadmium promotes nonalcoholic fatty liver disease by inhibiting intercellular mitochondrial transfer